Appendix 2

Public hearings and witnesses

Monday, 18 May 2017—Sydney

ARMSTRONG, Mr James, Member, Consumer Advisory Panel, GI-Cancer Institute, Australasian Gastro-Intestinal Trials Group

BARREAU, Ms Jackie, Member, Cancer Voices South Australia

BUCKLAND, Associate Professor Michael, Private capacity

BUTOW, Professor Phyllis, President, Clinical Oncology Society of Australia

CANFELL, Professor Karen, Director of Research, Cancer Council NSW, Cancer Council Australia

CHRISTENSEN, Ms Christine, Chair, Cancer Voices South Australia, and Executive Member, Cancer Voices Australia

CONLEY, Mr Russell, Chief Executive Officer, Australasian Gastro-Intestinal Trials Group

CULLEN, Mr Alexander, Ambassador, Cure Brain Cancer Foundation

ESLICK, Professor Guy, Professor of Cancer Epidemiology and Medical Statistics, University of Sydney

FERGUSON, Ms Linda, Private capacity

GRAEBER, Professor Manuel, Barnet-Cropper Chair of Brain Tumour Research, Brain and Mind Centre, University of Sydney

HARPER, Mr Todd, Chief Executive Officer, Cancer Council Victoria, Cancer Council Australia

JOHNS, Professor Terrance, Director, Brain Cancer Discovery Collaborative

KENT, Mr Dan, Past Chair, Consumer Advisory Panel, Australasian Gastro-Intestinal Trials Group

KOH, Dr Eng-Siew, Deputy Chair, Management Committee, and Deputy Chair, Scientific Advisory Committee, Cooperative Trials Group for Neuro-Oncology, NHMRC Clinical Trials Centre, University of Sydney

MARKER, Ms Julie, Executive Teams, Cancer Voices Australia and Cancer Voices South Australia

MARKER, Ms Julie, Member, Consumer Advisory Panel, Australasian Gastro-Intestinal Trials Group

MUMFORD, Ms Jan, Member, Consumer Advisory Panel, GI-Cancer Institute, Australasian Gastro-Intestinal Trials Group

O'NEILL, Associate Professor Geraldine, Chief Investigator, Brain Cancer Discovery Collaborative

ROSENTHAL, Professor Mark, Chair, Cooperative Trials Group for Neuro-Oncology, NHMRC Clinical Trials Centre, University of Sydney

SHONK, Mr Evan, Private capacity

SHONK, Mrs Margaret, Private capacity

SIMES, Professor R John, Executive Member, Cooperative Trials Group for Neuro-Oncology; and Director, NHMRC Clinical Trials Centre, University of Sydney

TURPIE, Mrs Suzanne, Private capacity

VINES, Mr Richard, Chief Executive Officer, Rare Cancers Australia

WOODS, Mrs Sandra Joy, Private capacity

Friday, 19 May 2017—Sydney

BYRNE, Professor Jennifer Anne, Head, Children's Cancer Research Unit, the Children's Hospital at Westmead

KELSO, Professor Anne, Chief Executive Officer, National Health and Medical Research Council

KERR, Mrs Jane, General Manager, Thoracic Cancer and Rare Lung Disease, Lung Foundation Australia

LEIGH, Ms Lillian, Consumer/Lung Cancer Patient Advocate, Lung Foundation Australia

ORCHARD, Mr Peter, Chief Executive Officer, CanTeen Australia

PARKINSON, Dr Jonathon, Chair, New South Wales Oncology Group, Neuro-oncology

PAVLAKIS, Associate Professor Nick, President, Australasian Lung Cancer Trials Group, Lung Foundation Australia

PETERS, Professor Matthew, Professor Respiratory Medicine, Thoracic Society of Australia and New Zealand         

STEIN, Dr Brian, Medical Oncology Group of Australia

Tuesday, 6 June 2017—Brisbane

ARMSTRONG, Ms Zoe, Clinical Research Director, Merck Sharpe & Dohme Australia

BUNT, Dr Jens, Research Fellow and Team Leader, NFI Research Lines, Brain Development and Disorders Laboratory, Queensland Brain Institute, The University of Queensland

BURGETT, Mrs Raechel, Private capacity

DAY, Dr Bryan William, Team Head, Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research Institute

LIM, Mrs Evangeline, Private capacity

LITTLEFIELD, Mr Barrie, Head of Engagement, Cure Brain Cancer Foundation

NELSON, Ms Marilyn, Private capacity

RAYMOND, Ms Emma, Theme Leader, Cancer, Wesley Medical Research

RICHARDS, Professor Linda, Deputy Director, Research, Queensland Brain Institute, The University of Queensland

SELLARS, Mr Christian, Director, Market Access and Public Affairs, Merck Sharpe & Dohme Australia

SPITERI, Mr Carmel, Team Leader, Market Access, Merck Sharpe & Dohme Australia

STEWART, Ms Michelle, Head of Research Strategy, Cure Brain Cancer Foundation

TAYLOR, Mrs Tracy, Private capacity

WADDELL, Dr Nicola, Group Leader, Medical Genomics Group, QIMR Berghofer Medical Research Institute

WALKER, Professor David, Private capacity

WHITEMAN, Professor David, Deputy Director, QIMR Berghofer Medical Research Institute

Wednesday, 7 June 2017—Melbourne

AKHURST, Mr Tom, Private capacity

DE ROSE, Dr Robert, Co-founder, The Isabella and Marcus Paediatric Brainstem Tumour Fund

FRASER, Dr Chris, Chair, Australian and New Zealand Children's Haematology/Oncology Group

GOTTARDO, Clinical Associate Professor Nicholas, Deputy Chair, Australian and New Zealand Children's Haematology/Oncology Group; and Chair, Central Nervous System Tumour Subcommittee, Australian and New Zealand Children's Haematology/Oncology Group

GOULBURN, Mr Daniel, Member, Pancreatic Cancer Alliance

GRAY, Mr Simon, Private capacity

GRAY, Mrs Carly, Private capacity

HERTZBERG, Professor Mark, Member and Director, Australasian Leukaemia and Lymphoma Group

JOHNSON, Dr Elizabeth, Program Manager, Victorian Comprehensive Cancer Centre

KEMPEN, Mr Peter, Chairman of the Board, Australasian Leukaemia and Lymphoma Group

LEYDEN, Ms Simone, Chief Executive Officer and Co-founder, Unicorn Foundation

MILLIS, Mrs Nicole, Executive Officer, Rare Voices Australia

MULLINS, Mr Greg, Head of Policy, Research Australia

PAJIC, Dr Marina, Group Leader, Garvan Institute of Medical Research

PEACOCK, Mrs Catherine, Private capacity

PERRY, Mr Dustin, Private capacity

ROBERTS, Professor Andrew, Member and Director, Australasian Leukaemia and Lymphoma Group

ROSENTHAL, Professor Mark, Clinical Trials Lead, Victorian Comprehensive Cancer Centre

SMITH, Ms Delaine, Chief Executive Officer, Australasian Leukaemia and Lymphoma Group

STRONG, Ms Robyn, Executive Officer, Australian and New Zealand Children's Haematology/Oncology Group

WESTHORPE, Mr Barry David, Chief Executive Officer, Pancare Foundation Inc.

WRIGHT, Associate Professor Gavin, Research and Education Lead, Lung Cancer, Victorian Comprehensive Cancer Centre

Thursday, 8 June 2017—Canberra

AUNEDI, Mrs Helen, Country Head, Country Clinical Operations, Roche Australia Pty Ltd

BERMAN, Mrs Tricia, Secretary, Brain Tumour Alliance Australia

DE SOMER, Ms Elizabeth, Director of Policy and Research, Medicines Australia

FRAZER, Professor Ian, Chair, Australian Medical Research Advisory Board

GRADY, Dr Melissa, Regional Director, Site Management and Monitoring, Asia Middle East and Africa Clinical Operations, AstraZeneca

HAMPTON, Ms Blanche, Head, Strategy and Partnership, Garvan Institute of Medical Research

HARVEY, Mr Justin, Unit Head, Cancer and Screening, Health Group, Australian Institute of Health and Welfare

HINDSON, Mrs Catherine, Chair, Brain Tumour Alliance Australia

MOON, Dr Lynelle, Group Head, Health Group, Australian Institute of Health and Welfare

PARSONS, Mrs Alice, Committee Member, Brain Tumour Alliance Australia

PITT, Ms Susan, Private capacity

SHEEHAN, Ms Nicola, Committee Member, Brain Tumour Alliance Australia

STEEL, Mr Philip, Vice-Chair, Brain Tumour Alliance Australia

STRANGMAN, Mr Denis, AM, Private capacity

THOMAS, Professor David, Director, The Kinghorn Cancer Centre; Head, Cancer Research Division, Garvan Institute of Medical Research

WILLIAMS, Mr William (Billy), Private capacity

Friday, 4 August 2017—Melbourne

BLAKEMORE, Mrs Carolyn, Consumer, Australian and New Zealand Children's Haematology/Oncology Group National Patient and Carer Advisory Group

BRIGGS, Miss Sophie, Private capacity

BRIGGS, Mrs Teresa, Private capacity

DENEHEY, Dr Sigrid, Private capacity

EMBERSON, Ms Jill, Patient and Consumer Advocate, Ovarian Cancer Australia

FOX, Professor Stephen, Director of Pathology, Peter MacCallum Cancer Centre

HARPER, Mr Todd Andrew, Chief Executive Officer, Cancer Council Victoria

HIBBERT, Mr Laurence, Member, Australian and New Zealand Children's Haematology/Oncology Group National Patient and Carer Advisory Group

HILL, Ms Jane, Chief Executive Officer, Ovarian Cancer Australia

IOCCO-FISCHER, Ms Melissa, Private capacity

KAY, Ms Anne, Chair, Australian and New Zealand Children's Haematology/Oncology Group National Patient and Carer Advisory Group

KENNEDY, Ms Laura, Private capacity

LAMBERT, Dr Ken, Private capacity

ROBERTS, Professor Andrew, Head of Clinical Translation, Walter and Eliza Hall Institute of Medical Research

SCOTT, Professor Clare Scott, Head, Rare Cancer Research, Walter and Eliza Hall Institute of Medical Research

SEYMOUR, Professor John, Director, Department of Haematology, and Associate Director, Clinical Research, Peter MacCallum Cancer Centre

SLOCOMBE, Dr Judith, Chair, Consumer Advisory Panel, Walter and Eliza Hall Institute of Medical Research

WITHINGTON, Mr Brett, Private capacity

Tuesday, 29 August 2017—Canberra

BUTT, Dr Alison, Senior Scientific Officer, Cancer Australia

CREELMAN, Ms Alice, Assistant Secretary, Department of Health

DE ABREU LOURENCO, Dr Richard, Member, Australian Health Economics Society

GILES, Adjunct Associate Professor Christine, Executive Director, Cancer Australia

GLOVER, Dr Julie, Acting Executive Director, Research Programs, National Health and Medical Research Council

HARTLAND, Mr Nicholas, First Assistant Secretary, Research, Data and Evaluation, Department of Health

JACKSON, Dr Paul, Acting General Manager, Knowledge Management, Cancer Australia

JENKINSON, Dr David, Chief Scientific Officer, The Brain Tumour Charity

KELSO, Professor Anne, Chief Executive Officer, National Health and Medical Research Council

KNEIPP, Ms Erica, Assistant Secretary, Department of Health

REYNOLDS, Ms Leanne, Head of Research, Pancreatic Cancer UK

SHAKESPEARE, Ms Penny, First Assistant Secretary, Department of Health

VINEY, Professor Rosalie, Member, Australian Health Economics Society

WILSON, Professor Andrew, Chair, Pharmaceutical Benefits Advisory Committee

Navigation: Previous Page | Contents

Top